Blueprint Medicines director Jeffrey Albers sells $511,400 in stock
CAMBRIDGE, MA—Jeffrey W. Albers, a director at Blueprint Medicines Corp (NASDAQ:), recently executed a significant stock transaction, according to a ...
Wednesday, April 2, 2025
Tag: Albers
Explore Israel's diverse narratives with The Israel Chronicle. Stay informed with unbiased reporting, insightful analysis, and comprehensive coverage of politics, culture, technology, and more. Discover the heartbeat of Israel through our trusted news platform.